Skip to main content

FDA Clears Immucor Blood Matching Platform

NEW YORK (360Dx) – Immucor  announced on Monday that the US Food and Drug Administration has cleared the company's Echo Lumena instrument for donor-patient blood matching.

The instrument is Immucor's fifth-generation immunohematology instrument, and with the fully automated NEO platform, they offer a standardized workflow solution for laboratories. Immucor added that with its data management solution, ImmuLink, labs will be able to combine serology and molecular immunohematology results into one view, improving their productivity.

Echo Lumena and the high-volume NEO instrument, the NEO Iris, are CE marked. The Echo family of instruments have more than 1,500 placements worldwide. Clinical trials for NEO Iris are underway in the US, Immucor said.